By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

MYND Life Sciences Inc. (MYNDF)

OTC Market Data in USD, Fundamentals in CAD
$0.03
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$2.44M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.07
52 Week Range

MYNDF Stock Price Chart

Explore MYND Life Sciences Inc. interactive price chart. Choose custom timeframes to analyze MYNDF price movements and trends.

MYNDF Company Profile

Discover essential business fundamentals and corporate details for MYND Life Sciences Inc. (MYNDF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

22 Sept 2021

Employees

CEO

Wilfred A. Jefferies

Description

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.

MYNDF Financial Timeline

Browse a chronological timeline of MYND Life Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

MYNDF Stock Performance

Access detailed MYNDF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run